Stroke detection start-up Viz.ai said its Viz CTP technology has been cleared by the US Food and Drug Administration ( FDA ). The company was founded after Mr. Golan suffered a brain event. The artificial intelligence (AI) technology analyses hospital Viz CTP scans for stroke indicators and automatically sends data to a doctor, with radiological images sent direct to their smartphone. It is the company's fifth the US Food and Drug Administration approval, after its computer-aided triage and notification platform for large vessel occlusion strokes was cleared in daily . San Francisco and Tel Aviv -based Viz.ai is looking to expand in the San Francisco and globally.
Stroke detection start-up Viz.ai said its Viz CTP technology has been cleared by the US Food and Drug Administration ( FDA ). The artificial intelligence (AI) technology analyses hospital Viz CTP scans for stroke indicators and automatically sends data to a doctor, with radiological images sent direct to their smartphone. It is the company's fifth the US Food and Drug Administration approval, after its computer-aided triage and notification platform for large vessel occlusion strokes was cleared in daily . San Francisco and Tel Aviv -based Viz.ai is looking to expand in the San Francisco and globally.